Role of the NMDA receptor subunit in the expression of the discriminative stimulus effect induced by ketamine (Q43662476)

25 November 2017

Role of the NMDA receptor subunit in the expression of the discriminative stimulus effect induced by ketamine (English)

1 reference

25 November 2017

M Narita

1

1 reference

25 November 2017

K Yoshizawa

2

1 reference

25 November 2017

M Nomura

3

1 reference

25 November 2017

K Aoki

4

1 reference

25 November 2017

T Suzuki

5

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 June 2001

1 reference

European Journal of Pharmacology

25 November 2017

1 reference

25 November 2017

423

1 reference

25 November 2017

1

1 reference

25 November 2017

41-46

1 reference

The NMDA antagonist model for schizophrenia: promise and pitfalls.

25 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901089-5

Antagonist properties of eliprodil and other NMDA receptor antagonists at rat NR1A/NR2A and NR1A/NR2B receptors expressed in Xenopus oocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901089-5

Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901089-5

Effects of atypical antipsychotic agents on social behavior in rodents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901089-5

Antipsychotic agents antagonize non-competitive N-methyl-D-aspartate antagonist-induced behaviors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901089-5

Modulation of NMDA and dopaminergic neurotransmissions by sigma ligands: possible implications for the treatment of psychiatric disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901089-5

PHARMACOLOGIC EFFECTS OF CI-581, A NEW DISSOCIATIVE ANESTHETIC, IN MAN.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901089-5

The N-methyl-d-aspartate antagonists phencyclidine, ketamine and dizocilpine as both behavioral and anatomical models of the dementias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901089-5

Neurobiology. Taking apart NMDA receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901089-5

Dizocilpine-like discriminative stimulus effects of low-affinity uncompetitive NMDA antagonists.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901089-5

Phencyclidine and sigma opiate receptors in brain: biochemical and autoradiographical differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901089-5

Stereospecific effects of ketamine on dopamine efflux and uptake in the rat nucleus accumbens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901089-5

Recent advances in the phencyclidine model of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901089-5

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901089-5

Molecular diversity of the NMDA receptor channel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901089-5

NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901089-5

Neuronal mechanisms of ketamine-induced anesthesia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901089-5

The excitatory amino acid receptors: their classes, pharmacology, and distinct properties in the function of the central nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901089-5

Heteromeric NMDA receptors: molecular and functional distinction of subtypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901089-5

Structure and function of the NMDA receptor channel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901089-5

Organization of N-methyl-D-aspartate glutamate receptor gene expression in the basal ganglia of the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901089-5

Interactions between H1-antagonists and opioids: a drug discrimination study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901089-5

Distinct distributions of five N-methyl-D-aspartate receptor channel subunit mRNAs in the forebrain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901089-5

1,3-Di(2-[5-3H]tolyl)guanidine: a selective ligand that labels sigma-type receptors for psychotomimetic opiates and antipsychotic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901089-5

Drug discrimination based on the competitive N-methyl-D-aspartate antagonist, NPC 12626.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901089-5

Intrathecal ketamine reduces morphine requirements in patients with terminal cancer pain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901089-5

10.1016/S0014-2999(01)01089-5

7 January 2021

Identifiers

DOI

1 reference

25 November 2017

1 reference